Stay updated on ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.

Latest updates to the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page
- Check6 days agoChange DetectedA new revision tag v3.3.2 was added and the previous v3.3.1 tag removed, indicating a minor version update with no changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedAdded a note in the Publications section stating that PubMed publications are automatically filled and may not pertain to the study, added a Revision: v3.3.1, and removed the older PubMed description and Revision: v3.2.0 text; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedNotice about government funding lapse was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe two screenshots show only minor UI tweaks with no changes to core study content, eligibility, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedNew operating-status notice and v3.2.0 release; prior v3.1.0 revision removed.SummaryDifference3%

- Check71 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.